Skip to content
Biodatica
Start free

Sunnybrook Health Sciences Centre

Toronto, Ontario

OncologyPhase III
Compare Sign in to watch

What changed

Phase III trial registered: Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

2d agoTrial registeredJul 17, 2026Source filing (opens the source filing in a new tab)

Momentum

78no change

Momentum 78 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase III

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

455 pre-ticker oncology companies at Phase III

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE3 registered

    Feb 27, 2025

    Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm · RECRUITING · sponsor: Children's Oncology Group · Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

    ClinicalTrials.gov · NCT06513962 (opens the source filing in a new tab)

  2. Trial

    Study registered

    Feb 20, 2025

    Diabetes Mellitus (Diagnosis), End Stage Renal Disease (ESRD), Dialysis, Continuous Glucose Monitoring · NOT_YET_RECRUITING · sponsor: Elaine Chow · CGM in Icodextrin PD

    ClinicalTrials.gov · NCT06838819 (opens the source filing in a new tab)

  3. Trial

    NA registered

    Feb 14, 2024

    Breast Cancer, Radiation Dermatitis · ACTIVE_NOT_RECRUITING · sponsor: Sunnybrook Health Sciences Centre · Efficacy Study With StrataXRT for the Prophylaxis of Radiation Dermatitis in Adjuvant Breast Radiation Treatment in Large Breasted Women Using a Prone Technique

    ClinicalTrials.gov · NCT06865131 (opens the source filing in a new tab)

  4. Trial

    NA registered

    Nov 11, 2022

    PreDiabetes, Impaired Glucose Tolerance · COMPLETED · sponsor: Elaine Chow · High FODMAP Diet With Metformin in preDM

    ClinicalTrials.gov · NCT05628584 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources